Sponsored by

Amid mixed signals, evidence hints that public biotechs are bouncing back

While biotech IPOs have been all over the map, one analyst offered a few promising signs of recovery over the weekend.

MGH, Dana Farber help enable cancer combo trials through CoNNCT Initiative

The goal of the effort is to start a nonprofit that would speed up the process of testing new, experimental cancer drugs in combination with each other.

​Boston’s 908 Devices launches first product aimed at the life science lab market

The so-called ZipChip allows for faster separation of large and small molecules in samples of blood, plasma and other biological liquids so they can be analyzed using mass spectrometry.

State insurance chief urges carriers to push back on high-cost hospitals

The state’s top insurance regulator has cautioned insurers to reign in spending by taking a tougher stand on the amounts being paid to care providers.

Unicorn herd still grazing in San Francisco Bay Area despite market disruptions

Salesforce puts meditation rooms on every floor after monks visit